Table 3 Data analysis of the clinical neurological damage caused by different pathogens

Total (n)

65(70.7%)

19(20.7%)

8(8.7%)

92

Encephalitis (n) ^#

39(60%)

16(82.4%)

6(75%)

0.125

61(66.3%)

Acute flaccid paralysis (n) ^#

2(3%)

1(5.3%)

0

0.772

3(3.3%)

Brainstem encephalitis (n) ^#

8(12.3%)

2(1.1%)

0

0.572

10(10.9%)

Neurogenic pulmonary edema (n) ^#

11(16.9%)

0

1(12.5%)

0.047

11(12%)

Neurologic shock (n) ^#

5(7.7%)

0

1(12.5%)

0.215

6(6.5%)

Limb shaking (n)

51(78.5%)

15(78.9%)

6(75%)

0.973

72(78.3%)

Convulsion (n)

21(32.3%)

4(21.1%)

2(25%)

0.613

27(29.3%)

Vomiting (n)

42(64.6%)

16(84.2%)

7(87.5%)

0.141

65(70.7%)

Fatigue (n)

47(72.3%)

17(89.5%)

5(62.5%)

0.219

69(75%)

Coma (n)

24(36.9%)

2(10.5%)

1(12.5%)

0.046

27(29.3%)

Limb movement disorder (n)

34(52.3%)

3(15.8%)

2(25%)

0.010

39(42.4%)

Urinary retention (n)

31(47.7%)

6(31.6%)

2(25%)

0.266

39(42.4%)

CSFWBC > 10 × 10 ⁶ /L (n) ^§

21/44(47.7%)

8/14(57.1%)

3/6(50%)

0.828

25/64(39.1%)

CSFPro ≥ 0.5 g/L (n) ^§

15/44(34.1%)

5/14(35.7%)

2/6(33.3%)

0.992

22/64(34.4%)

Ambulatory EEG abnormality (n) ^§

17/32(53.1%)

4/13(30.8%)

1/5(20%)

0.205

22/50(44%)

Head MRI abnormality (n) ^§

13/32(40.6%)

5/15(33.3%)

2/6(33.3%)

0.685

20/53(37.7%)

Patients with dysfunction upon discharge (n)

11(16.9%)

1(5.3%)

1(12.5%)

0.435

13(14.1%)

Death (n) ^¤

5(7.7%)

0

0

0.333

5(5.4%)